NT-proBNP to Exclude cardiovascular Complications in Patients with Diabetes mellitus Type 2

被引：0
|
作者：
Resl, M. [1 ]
Huelsmann, M. [2 ]
Pacher, R. [2 ]
Luger, A. [2 ]
Clodi, M. [3 ]
机构：
[1] Med Univ Wien, Klin Abt Endokrinol & Stoffwechsel, Univ Klin Innere Med 3, Vienna, Austria
[2] Med Univ Wien, Klin Abt Kardiol, Univ Klin Innere Med 2, Vienna, Austria
[3] Konventhosp Barmherzigen Bruder Linz, Innere Med Abt, Linz, Austria
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2013年 / 125卷 / 17-18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：559 / 559
页数：1
相关论文
共 50 条
  • [1] NT-proBNP to Exclude cardiovascular Complications in Patients with Type 2 Diabetes mellitus
    Resl, Michael
    Neuhold, Stephanie
    Prager, Rudolf
    Brath, Helmut
    Francesconi, Claudia
    Luger, Anton
    Pacher, Richard
    Huelsmann, Martin
    Clodi, Martin
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 : S9 - S9
  • [2] NT-proBNP in normoalbuminuric patients with Type 2 diabetes mellitus
    Andersen, NH
    Poulsen, SH
    Knudsen, ST
    Heickendorff, L
    Mogensen, CE
    DIABETIC MEDICINE, 2005, 22 (02) : 188 - 195
  • [3] NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes
    Bolivar Malachias, Marcus Vinicius
    Wijkman, Magnus Olof
    Bertoluci, Marcello Casaccia
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
  • [4] NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes
    Marcus Vinicius Bolivar Malachias
    Magnus Olof Wijkman
    Marcello Casaccia Bertoluci
    Diabetology & Metabolic Syndrome, 14
  • [5] NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus
    Malachias, Marcus V. B.
    Jhund, Pardeep S.
    Claggett, Brian L.
    Wijkman, Magnus O.
    Bentley-Lewis, Rhonda
    Chaturvedi, Nishi
    Desai, Akshay S.
    Haffner, Steven M.
    Parving, Hans-Henrik
    Prescott, Margaret F.
    Solomon, Scott D.
    De Zeeuw, Dick
    McMurray, John J., V
    Pfeffer, Marc A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (19):
  • [6] The Implication of NT-proBNP in the Assessment of the Clinical Phenotype of Patients with Type 2 Diabetes Mellitus, Without Established Cardiovascular Disease
    Gastouniotis, Ioannis
    Fragoulis, Christos
    Antonopoulos, Alexis
    Kouroutzoglou, Alexandrina
    Noutsou, Marina
    Thanopoulou, Anastasia
    Chrysohoou, Christina
    Tsioufis, Konstantinos P.
    BIOMEDICINES, 2024, 12 (12)
  • [7] NT-PROBNP AND HSTNT IMPROVE CARDIOVASCULAR RISK PREDICTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS, CHRONIC KIDNEY OR CARDIOVASCULAR DISEASE OR BOTH
    Jhund, Pardeep
    Claggett, Brian
    Pfeffer, Marc
    Bentley-Lewis, Rhonda
    Brenner, Barry M.
    Brunel, Patrick
    Chaturvedi, Nishi
    Desai, Akshay
    Haffner, Steven
    Parving, Hans-Henrik
    Prescott, Margaret
    Solomon, Scott
    De Zeeuw, Dick
    McMurray, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1279 - A1279
  • [8] Serial monitoring of NT-proBNP predicts heart failure in patients with type 2 diabetes mellitus
    Jarolim, P. Petr
    White, W. B.
    Cannon, C. P.
    Gao, Q.
    Morrow, D. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 30 - 30
  • [9] NT-proBNP levels in the type 2 diabetes mellitus population: An observational study
    Strelzow, J
    Aydin, C
    Bondy, G
    Tildesley, HD
    DIABETES, 2005, 54 : A521 - A521
  • [10] Testosterone and NT-proBNP in Type 2 Diabetes mellitus infected men.
    Resl, Michael
    Prager, Rudolf
    Pacher, Richard
    Huelsmann, Martin
    Luger, Anton
    Neuhold, Stephanie
    Elhenicky, Marie
    Kautzky-Willer, Alexandra
    Clodi, Martin
    Abrahamian, Heidemarie
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 : S23 - S23
12345